chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea; a little sore in her right arm; abdominal pain; thirsty; This is a spontaneous report received from a contactable consumer (patient) reported herself via a Pfizer sponsored program. A 59-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration at right arm on 23Aug2021 (at the age of 59-year-old) as dose 2, single for COVID-19 immunisation. The patient's medical history included diabetes. Concomitant medications included metformin and she was a diabetic and she takes Metformin medication and other medications she takes every day such as she takes medication for cholesterol and triglycerides, but her medication has been the same since before her first shot. No further details provided about her medications. Patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EW0175) via an unspecified route of administration at right arm on 04Aug2021 (at the age of 59-year-old) as dose 1, single for COVID-19 immunisation. It was reported that caller stated that she got her 2nd dose of the Pfizer BioNTech covid-19 Vaccine yesterday and experienced abdominal pain in the evening. Caller wanted to know if abdominal pain and diarrhea are among the commonly reported adverse events after getting the Pfizer BioNtech covid-19 vaccine. Caller wanted to know if there was a need for her to self-isolate after receiving her 2nd dose of the Pfizer BioNTech covid-19 vaccine and if she was still experiencing diarrhea and abdominal pain after being vaccinated. Caller says she was concerned because she lives with her mom who was 85 years old and sometimes her brother who lives in the front of the house wants her to take care of their children, on whether this was just a side effect or should she be isolating herself from people. She says she got both doses given to her in her right arm. She says after getting shot she was a little sore in her right arm, and then last night she had abdominal pain and woke up with diarrhea. Caller says that has stayed the same, and she hasn't eaten since she still has abdominal pain in there. She says she has done no treatment other than not eating, which was another thing, it was not on side effect list but she has been thirsty a lot, she does not know if that was normal. The patient experienced abdominal pain, a little sore in her right arm on 23Aug2021, diarrhea on 24Aug2021 and thirsty on Aug2021. Patient did not receive any treatment for the events. Outcome of all events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Myalgia Arthralgia, Fever, NauseaVomiting, Chills, fatigue Narrative:
Patient has passed 35 days without second dose; Developed hives all over the body; Body itching; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Apr-2021 and was forwarded to Moderna on 29-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Developed hives all over the body), PRURITUS (Body itching) and PRODUCT DOSE OMISSION ISSUE (Patient has passed 35 days without second dose) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032A20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced URTICARIA (Developed hives all over the body) and PRURITUS (Body itching). On 29-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has passed 35 days without second dose). At the time of the report, URTICARIA (Developed hives all over the body), PRURITUS (Body itching) and PRODUCT DOSE OMISSION ISSUE (Patient has passed 35 days without second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Steroid shot, Prednisolone, Sodium Chloride, Diphenhydramine, Methyl prednisone and Famotidine.
Patient stated the day after vaccination that he had severe fatigue and a rash with itching that extended over his whole body.  He stated the rash and itching subsided after 2 days but was still present.  Patient is continuing to have itching and rash present.  Patient is using hydrocortisone cream to calm the itching.  We suggested to take diphenhydramine tablets and follow up with doctor if itching continues.
The pain is worse with movement and when lifting heavy objects; a little rash like little white dots over this area; chest pain; chest pain is localized to the breast bone, and in his neck area.; Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), NECK PAIN (chest pain is localized to the breast bone, and in his neck area.), PAIN (The pain is worse with movement and when lifting heavy objects), RASH (a little rash like little white dots over this area) and VACCINATION SITE PAIN (Sore left arm) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (He stayed overnight in a hospital with that diagnosis, but does not recall receiving any treatments) on 10-Dec-2020, Cough (since before taking the vaccine) and Cold (since before taking the vaccine).    On 31-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2022, the patient experienced VACCINATION SITE PAIN (Sore left arm). On 02-Jan-2022, the patient experienced CHEST PAIN (chest pain), NECK PAIN (chest pain is localized to the breast bone, and in his neck area.) and RASH (a little rash like little white dots over this area). On an unknown date, the patient experienced PAIN (The pain is worse with movement and when lifting heavy objects). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and ALCOHOL at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain) and NECK PAIN (chest pain is localized to the breast bone, and in his neck area.) had not resolved, PAIN (The pain is worse with movement and when lifting heavy objects) and RASH (a little rash like little white dots over this area) outcome was unknown and VACCINATION SITE PAIN (Sore left arm) had resolved.            No prior history of myocarditis or pericarditis.  No Concomitant medication was reported.  Patient had chest pain on 2 JAN 2022 which had continued up until that day. This chest pain was localized to the breast bone, and in his neck area. These was also a little rash like little white dots over this area. The pain was worse with movement and when lifting heavy objects.   This case was linked to MOD-2022-448106 (Patient Link).
On April 12th, patient became febrile, nauseated and complained of body aches.  The injection site was swollen, erythemic and measured about 10 cm in length.  Today, April 14th, injection site is greatly impoved and patient is afebrile.
Started 31 March with moderate pain to left armpit, increased to sharp pain with movement.  Red linear elevated/inflammation rash from site wrapping around to left armpit. temperature of skin is warm around bicep.
Information has been received from a physician concerning a 17 year old female who on approximately 19-Nov-2007 was vaccinated with the second dose of Gardasil.  On 20-Nov-2007, within 24 hours of receiving the vaccine, the patient experienced dizziness.  The patient was subsequently admitted to the hospital, however the length of stay was unknown.  The reporting physician that had heard of this event is not this patient's physician.  At the time of this report, the outcome of the event was unknown.  No further information is available.
pt recvd vax;became pale,breathing was labored,had slobbers running out of mouth;lethargic,limp,was choking;v;hands jerking;sz,t 102R;on IV & atbs;ear infect;MD felt febrile sz;face quiver,eyes rolled back;screamed uncontrollably,in pain;
Patient received an expired Moderna covid vaccine on 9/8/21. No adverse reaction reported or noted.
86 y/o female c/o throat swelling 12 minutes after receiving vaccine while in the recovery area for 15 minute recovery period.  Vitals were stable, AAO x4, denied SOB, no visible throat swelling or redness, no dizziness, speaking clearly and in complete sentences, lungs clear to auscultation.  EMS call @ 0922, arrived @ 0935, assessment completed, no worsening of condition, felt the same, declined transport to local ED, signed waiver.  Remained in recovery for additional 15 minutes, DC from recovery @ 0950 accompanied by Adult Daughter throughout the incident, stable at DC.
COVID 19 Treatment/ Treatment of COVID-19; COVID 19 Treatment/ Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Batch/Lot number: unknown), in right arm, on 26Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 26Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm and on 28Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 76 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "high bp" (unspecified if ongoing). Concomitant medication(s) included: OLMESARTAN MEDOXOMIL, start date: 01Dec2020, stop date: 26Jul2022. Past drug history included: Norflex, reaction(s): "drug allergy"; Clindamycin, reaction(s): "drug allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "recovering" and all described as "COVID 19 Treatment/ Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course included: Adverse event noted exhibited all symptoms of covid ba5 variant. Anti-Viral details noted as product noted as COVID 19 Treatment; brand noted as Paxlovid; treatment start date noted as 14Jul2022; treatment stop date noted as 19Jul2022; and indication noted as treatment of COVID-19.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Right and left leg weakness, numbness,  diagnosed with Guillion Barre Syndrome hospitalized for 7 days
Had my appendix removed and a right hemicolectomy to remove highly inflamed and infected tissue; abdominal pain/ pain localized to the lower right quadrant of my abdomen; fever; This is a spontaneous report from a contactable consumer (patient herself). A 50-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration, administered in Arm Left, Age at Vaccination: 50 Years, on 22Jan2021 10:15 (Batch/Lot Number: EL1283) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Feb2021, On day 8 pain localized to the lower right quadrant of her abdomen and she ran a fever, also reported as 13 days after her first vaccination dose, patient began to experience abdominal pain. Patient went to the emergency room on an unspecified date in 2021. Patient had her appendix removed and a right hemicolectomy to remove highly inflamed and infected tissue. Patient was hospitalized for 5 days on unspecified date in 2021. The adverse event resulted in emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered: Hospital. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered in 2021. Seriousness criteria-Caused/prolonged hospitalization. Patient had her second dose of Pfizer COVID-19 vaccine on 12Feb2021 at 11:00 AM in the left arm for COVID-19 immunisation.
Patient reported difficulty swallowing along with throat swelling. she became diaphoretic along with slight hypoxia to 93% requiring supplemental oxygen
27 year old female who became symptomatic 30 minutes after receiving MMR vaccine. No previous problems with receiving vaccines as a child. Developed chest pain, numbness, and weakness down right arm. BP 122/76 - Pulse 70; Resp: 18 Temp: 36 O & SAT 99% medicated with BENADRYL 50mg, SOLUMEDROL and FAMOTIDINE - symptoms resolved.
Began having symptoms of disautonomia 5 days post vaccine. Symptoms included: dizziness, vertigo, SOB, heart palpitations, tachycardia, tachycardia upon standing, panic episodes, feeling faint, slow visual processing, visual "floaters", fatigue, brain fog. Has gotten progressively worse since then, and was recently diagnosed with postural orthostatic tachycardia syndrome and was advised to report to CDC by primary care doctor.
On 8/11/21, patient completed the 15-min observation period.  She was on her way out of the warehouse when she experienced chest pain.  She sat back down on the chair and paramedics was called.  She was checked out ok but declined to go to the hospital.  She stayed at the pharmacy for 20 minutes and left with her friend.  She will get the second dose at the hospital where she can be closely monitored.
Exceeded dosing interval; Fatigue; A spontaneous report (United States) was received from a consumer for a 78 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue. It was known the patient had exceeded dosing interval.  The patient's medical history included chronic obstructive pulmonary disease. Concomitant medication included inhaler.  On 29-Jan-2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 012L20A) intramuscularly for prophylaxis of COVID-19 infection. It was known the patient had exceeded the dosing interval. On 29-Jan-2021, an unspecified interval after receiving the vaccine the patient experienced fatigue.  Treatment information was unknown.  Action taken with mRNA-1273 was unknown.  The outcome of the events, exceeded dosing interval was not applicable and for the event fatigue was unknown.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273, lot 012L20A with no associated AEs. Based on the current available information and temporal association between the use of the product and the start date of the fatigue, a causal relationship cannot be excluded.
Shingles; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN5318), via an unspecified route of administration (Injected into left arm up high below the shoulder) on 04Feb2021 (at age of 68 years old) at single dose for COVID-19 immunization. Medical history reported as none. There were no concomitant medications. The patient experienced shingles on 05Feb2021. The outcome of event was unknown. She did not know if it was related and didn't care. Her concern was the ER doctor did not seem to be too concerned. The pharmacist thought she should call and let Pfizer know and tell her what to do next. She would like to know if she should continue to get next shot. She had not heard it was one of the side effects. She stated she was hoping she nipped it in the bud, but said it would get worse. If got shingles like any herpes virus, if take the medication at the onset, it help with the breakout. It still took two weeks to get out of system. She had a lot of fat and was not sure if it went into the muscle.
I did not have an adverse reaction to the vaccine but I tested positive for Covid 19 on 05/31/2022. I started feeling symptoms 05/28/22 congestion and stuffy nose. On Tuesday I woke up with a scratchy throat. I tested with a home test on 05/31/22 and it was positive. I had a telehealth visit with my doctors office and they prescribed an prescription of Paxlovid. I'm starting to feel better. Prior to testing positive for Covid 19 I used a saline nose spray to relieve congestion.
Chest pain; Fast heartbeat; I have been experiencing heart palpitations; Chills; Upset; Not really good; unwell; So, it is in my heart/my heart is (distortion)/that it is not really good; very severe headaches; This is a spontaneous report from a contactable consumer. This 27-year-old female consumer (patient) reported that.  A 27-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: FC3183), dose 1 via an unspecified route of administration, administered in Arm Left on 14Sep2021 as (At the age of 27-years) dose 1, single for covid-19 immunisation. Medical history included from an unknown date and unknown if ongoing. There were no concomitant medications. No Other Products, Patient History and No Investigation Assessment. The patient experienced chest pain, fast heartbeat, i have been experiencing heart palpitations, chills, upset, not really good; unwell, so, it is in my heart/my heart is (distortion)/that it is not really good, very severe headaches on 15Sep2021. It was reported that she got the COVID Vaccine, the Pfizer one 14Sep2021 and it was reported that she has fast heartbeat, some chills, she just feeling just generally upset, unwell, some nausea, headaches, very severe headaches and every now and then she gets chest pain as well. Later she started she was experiencing negative effects and symptoms on the 15Sep the next day (2021). It has gotten a little bit better, but it is kind of, his heart is (distortion). So, that it is not really good. It was reported that patient did not take second dose because, she has been experiencing heart palpitations, she does not think it is in his health interest to take it. Patient did not receive any treatment for events, she had gotten this vaccine on the 14Sep, and it is 20Sep. So, it has been only a couple of days. She read that these experiences are normal for one day, two days after but now it is kind of been 5th day now. So, tomorrow she will be going to urgent care to get a doctor opinion. Consumer was informed about the Role of Pfizer Drug Safety. Consumer further stated, "what you would recommend I do. Do you just take the information about the side effects. You tend to take the data." Consumer was requested to contact health care provider for the recommendation. Consumer was provided with the number of Pfizer Medical Information. The outcome of events was recovering at the time of report.  Follow-up attempts are completed. No further information is expected.
Painful injection site after 10 minutes of injection that lasted for about 2 hours, then it was only sore. After about 2 hours, I started to had a bad headache and pain and numbness under my left jaw.
BLOOD CLOTS IN LUNGS; NUMBNESS IN HANDS AND FEET; SWELLING IN HANDS AND FEET; This spontaneous report received from a patient concerned a 58 year old white male. Initial information was processed along with the additional information received on 11-MAY-2021  The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no history of blood clots. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 207A21A expiry: UNKNOWN) dose was not reported, 1 total administered to right deltoid on 09-APR-2021 around 13:00 for prophylactic vaccination. No concomitant medications were reported.  After receiving the vaccination on 09-APR-2021, the patient went home and slept for 6 hours. One week after vaccination, on 12-APR-2021 the patient experienced swelling in hands and feet. Two weeks after, on 19-APR-2021 the patient experienced numbness in hands and feet. On 21-APR-2021, the patient went to the emergency room (ER) and was given the tests, laboratory data included: Blood test (NR: not provided) unknown, CAT scan (NR: not provided) blood clots in lungs, and EKG (NR: not provided) unknown. The patient experienced blood clots in lungs and was hospitalized. On 22-APR-2021, laboratory data included: Sonogram (NR: not provided) results awaiting and will get records on wednesday.  As of 22-APR-2021 the patient was started on blood thinner. Treatment medications included: apixaban (Eliquis) 2 a day. On an unspecified date in APR-2021 while in the hospital the patient was on oxygen (unspecified indication). The patient was discharged on 22-APR-2021 and the duration of hospitalization was 1 day. The patient was released with a prescription of Eliquis for 3 months. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) negative.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swelling in hands and feet, numbness in hands and feet, and blood clots in lungs. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0 20210518013 -COVID-19 VACCINE AD26.COV2.S- Blood Clots in lungs . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
11 days after 1st shot an EKG showed Irregular Heart beats; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 18Mar2021 at 10:15 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and gastroesophageal reflux disease (GERD). The patient received unspecified medications within two weeks of vaccination. The patient previously received Morphine and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Feb2021, the patient underwent lab test and procedures which included stress test and carotid artery test and everything was good. On 28Mar2021 at 16:00, 11 days after 1st shot, an electrocardiogram (EKG) showed irregular heartbeats. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 11 days after 1st shot an EKG showed Irregular Heart beats was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
The patient had received the flu shot and later developed the redness on her arms and face.  As per the patient, it wasn't a rash, and the redness disappeared fairly quickly after taking a dose of benadryl.  She is fine now and is fully recovered.
child adm to ER 4FEB99 less than 30 days p/vax;pt presented to ER in resp distress, T101, retractions;intubated;had bradycardia then loss of pulse, expired 1105pm 4Feb99, cause of death: pneumonia
On 4/6/01 and 5/18/01, the pt received her 1st and 2nd doses of Engerix-B, respectively. Post vax, on 5/10/01, she experienced nausea, dizziness, palpitation, cold sweats and pallor. As of 6/20/01, the events had resolved.